Improving the targeting of therapeutics with single-domain antibodies.
about
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsSindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
P2860
Improving the targeting of therapeutics with single-domain antibodies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improving the targeting of therapeutics with single-domain antibodies.
@en
type
label
Improving the targeting of therapeutics with single-domain antibodies.
@en
prefLabel
Improving the targeting of therapeutics with single-domain antibodies.
@en
P2860
P1476
Improving the targeting of therapeutics with single-domain antibodies
@en
P2093
Igor L Medintz
Kendrick B Turner
P2860
P304
P356
10.1517/17425247.2016.1133583
P407
P577
2016-01-25T00:00:00Z